Alternative strategies appear overall attractive but dispersion across strategies might be high, said Lyxor in its weekly brief.

"As we start 2019, we are positioned around three axes: reduce exposure to high beta strategies, reduce sensitivity to Momentum, and leverage on the U.S. M&A cycle," said Lyxor's Cross Asset Research team.

"We maintain our overweigh